What Smartqare does

smartQare B.V. is a Dutch medical-technology company founded in 2017 and headquartered in Noordwijk (Eindhoven office at Strijp S), developing CE Class IIa-certified wearable remote patient monitoring (RPM) solutions. Its two core products — viQtor (an upper-arm multi-sensor wearable using PPG, accelerometer, gyroscope, barometer, and GNSS) and the Healthdot 3.1 chest biosensor — stream continuous vital signs (heart rate, respiratory rate, SpO2, skin temperature, activity, fall detection, location) directly to a cloud platform over LTE-M/NB-IoT or LoRa networks, eliminating the need for Bluetooth gateways, smartphones, or hospital Wi-Fi. Both devices are MDR Class IIa certified by Notified Body Kiwa Dare, and the company holds ISO 13485.

The platform targets hospitals, hospital-at-home/transitional care, and home care/district nursing organizations — specifically the monitoring gap between ICU continuous monitoring and intermittent ward spot-checks, including pre/post-operative patients, chronic disease patients (COPD, heart failure), and elderly living independently. SmartQare pursues enterprise field sales in the Netherlands and Europe alongside a strategic partnership signed with Royal Philips in January/April 2024, under which the integrated viQtor + Healthdot solution is co-sold globally (starting in Europe), with Philips retaining Legal Manufacturer status for Healthdot and providing HealthSuite Digital Platform (HSDP) hosting.

Revenue is generated through Class IIa medical device hardware sales, recurring cloud platform/dashboard subscriptions with EHR/EMR/ECD/EPD/HIS API integrations, and jointly delivered managed RPM services via Philips. Pricing is quote-based, tailored to enterprise contracts. The company has received an OpZuid EFRO R&D subsidy (June 2023), is part of the Brainport Eindhoven medtech ecosystem, and continues to scale Living Lab pilots with Sensire, NAAST-ZCN, Catharina Ziekenhuis, and LUMC into broader commercial deployments.

Name

Smartqare

Legal name

smartQare B.V.

Website

https://smartqare.nl

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industries

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration) (HLACAPAJ)

Keywords

• Remote patient monitoring
• Wearable medical devices
• Continuous vital sign monitoring
• Clinical decision support
• Connected health sensors

Headquarters

HQ city

Noordwijk

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Wearable Medical Device Sales: SmartQare generates revenue from the sale of its medical-grade wearable monitoring devices (viQtor and Healthdot 3.1). Both are certified Class IIa medical devices sold to healthcare organizations, hospitals, and home care providers.
2. RPM Platform / Software Subscriptions: The company offers a cloud-based monitoring platform and dashboards accessible to healthcare professionals. Data is transmitted from wearables directly to the platform, with alerts and trend analyses provided to care teams. The platform integrates with electronic health record systems (ECD/EPD/HIS) via APIs.
3. Integrated RPM Solution (via Philips Partnership): Following the 2024 Philips partnership, SmartQare combines viQtor and Healthdot RPM into one digital solution and platform, offered jointly by SmartQare and Philips to healthcare providers globally. Philips remains the legal manufacturer of Healthdot 3.1.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

SmartQare develops and sells medical-grade wearable biosensors (viQtor upper-arm multi-sensor and Healthdot 3.1 chest biosensor) combined with a cloud-based remote patient monitoring platform that delivers 24/7 continuous vital sign monitoring, fall detection, and clinical decision support to hospitals, hospital-at-home programs, and home care providers. Both devices are EU MDR Class IIa certified and transmit data directly to the cloud via cellular IoT (NB-IoT/LTE-M) and LoRa networks without requiring smartphones or gateways.

Product overview

Smartqare offers a comprehensive remote patient monitoring ecosystem consisting of two primary wearable devices: viQtor (upper arm-worn multi-sensor monitor) and Healthdot 3.1 (chest-worn biosensor). The viQtor solution includes the wearable device, cloud platform with dashboards, and mobile app for continuous vital signs monitoring. Healthdot 3.1 is designed for shorter-term monitoring during hospital-to-home transitions. Both devices feed data into the smartQare platform, which provides clinical decision support through continuous Early Warning Scores, trend analysis, and automated alerts. The company partnered with Philips in 2024 to integrate these solutions with Philips clinical software platforms.

Differentiator

Problem solved

Functional benefit

Brands

• viQtor: A wearable multisensor solution for 24-hour monitoring of vital signs including heart rate, oxygen saturation, skin temperature, activity, fall detection, and location. CE certified Class IIa medical device.
• Healthdot 3.1

Products and services

• viQtor Upper-arm worn CE Class IIa medical device that continuously measures heart rate (30–240 bpm), respiratory rate (5–40 BRPM), SpO2 (70–100%), skin temperature (20–42.5°C), activity, and detects falls with GNSS location, transmitting data directly to the cloud over Vodafone NB-IoT/LTE-M with 5–7 day battery life. Sold to hospitals and home care organizations.
• Healthdot 3.1 Lightweight (13.6g) IP55 splash-proof chest-worn CE Class IIa medical device that continuously monitors heart rate (30–220 bpm) and respiratory rate (5–60 rpm) using accelerometer-based technology, transmitting over LoRa networks with 14-day battery life for short-duration post-discharge and hospital-to-home transitions.
• smartQare Platform (Integrated RPM Platform) Cloud-based integrated remote patient monitoring platform combining viQtor and Healthdot 3.1 device data with dashboards, continuous Early Warning Score (cEWS), trend analysis, configurable threshold alerts, and API integration to hospital EHR/EMR/ECD/EPD/HIS systems, co-sold with Philips to healthcare providers worldwide.

Quantifiable outcome

• 62% reduction in manual nursing measurements per patient per day, saving approximately 10 minutes per patient per day
• +5 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability9 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Koninklijke Philips N.V. (Royal Philips)coreStrategic or Co-development Partner · 4 April 2024In April 2024 (formal announcement), Philips announced a strategic partnership to integrate SmartQare's technology with its clinical software platforms for patient monitoring. SmartQare combines its viQtor solution with Philips' Healthdot 3.1 into one digital RPM platform. Philips remains the legal manufacturer of Healthdot 3.1. The integrated solution is co-sold by both companies to healthcare providers globally, starting in Europe. Philips also provides access to its HealthSuite Digital Platform (HSDP) for secure data storage (EU/Ireland, ISO 27001, 27018, SOC II, HiTRUST).
• Koninklijke Philips N.V. (Royal Philips)coreStrategic or Co-development Partner · 11 January 2024In January 2024 (initial signing), SmartQare and Philips signed a strategic partnership agreement in the presence of His Royal Highness Prince Constantijn van Oranje (Techleap.nl Special Envoy). SmartQare committed to merging viQtor and Healthdot RPM portfolios into one digital solution and platform, with Philips supporting global go-to-market. The transaction was expected to close in Q1 2024.
• LUMC (Leids Universitair Medisch Centrum)minorStrategic or Co-development Partner · 1 January 2021LUMC, led by anesthesiologist Dr. Rutger van der Schrier, calibrated and validated viQtor's oxygen saturation measurements in late 2021. This clinical validation was a critical step toward CE Class IIa certification, providing independent medical institution endorsement of viQtor's SpO2 accuracy.
• Kiwa Dare (Notified Body)minorOthers · 1 January 2021Kiwa Dare is the Notified Body that audited SmartQare's quality management system and issued viQtor's CE Class IIa certification under EU MDR (EU) 2017/745. Kiwa Dare's 4-digit identification number (0404) appears on the CE marking.
• SensireminorStrategic or Co-development PartnerSensire, the largest home care organization in East Gelderland, was SmartQare's first Living Lab pilot partner. Clinicians used viQtor with real patients, providing feedback on clinical workflow integration, wear comfort, and monitoring outcomes. This pilot helped validate viQtor's practical utility and generated testimonials for clinical evidence.
• NAAST-ZCNminorImplementation/ SI/ Consulting PartnerNAAST-ZCN is a medical service center (medisch service centrum) that partners with SmartQare and Sensire in Living Lab pilots. NAAST-ZCN provides 24/7 monitoring of clients, receives alerts from viQtor, and initiates protocol-driven actions (contacting clients, families, neighbors) before escalating to professional caregivers. Functions as the human monitoring tier in the care escalation protocol.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Current Health (Best Buy Health): Current Health provides a continuous vital-sign monitoring wearable and RPM platform for hospital-at-home and chronic care management, now part of Best Buy Health. Closely matches SmartQare's RPM+wearable+platform stack and target use cases.
• Vivify Health: Vivify Health offers an RPM platform with BYOD and kit options for chronic care, post-discharge, and population health. Comparable to SmartQare in RPM-as-a-service delivery for health systems and home care.
• Biofourmis: Biofourmis is a continuous RPM platform combining wearable biosensors with AI-driven analytics for hospital-at-home and post-discharge monitoring. Directly comparable to SmartQare's viQtor + Healthdot solution across care-setting coverage and clinical decision-support algorithms.

Emerging players

• iRhythm Technologies: iRhythm's Zio wearable patch provides continuous ambulatory cardiac monitoring with AI-based arrhythmia detection. Comparable technology category (medical-grade wearable biosensor with AI-driven clinical reporting) though focused on cardiac arrhythmia rather than multi-parameter vitals.
• Huma (formerly Medopad): Huma operates a 'hospital-at-home' RPM platform combining device-agnostic data collection with predictive algorithms. Comparable as an emerging RPM platform competitor targeting the same European health systems and pharma-sponsored deployments.
• VivaLnk: VivaLnk makes medical-grade wearable patches and sensors (e.g., eSkin) used for continuous vitals monitoring and RPM integrations. Comparable as a connected medical-wearable vendor whose products compete for embedding into hospital RPM deployments.

Broad incumbents

• Masimo: Masimo is a global medtech incumbent with patient-worn continuous monitoring (e.g., Radius PPG, SedLine) used in hospital and home settings. Comparable in technology category (continuous SpO2 and vitals) but competes as a broader portfolio vendor rather than an RPM-only specialist.
• Medtronic: Medtronic runs remote cardiac monitoring (LINQ insertable cardiac monitor, connected CareLink) and broader hospital patient monitoring. Comparable on continuous vital-sign telemetry and remote data transmission into clinical platforms.
• Philips: Royal Philips is SmartQare's strategic partner and runs its own RPM and patient monitoring portfolio (including the legacy Healthdot platform now transferred to SmartQare). Comparable because it competes and partners with SmartQare across the same continuous monitoring use cases and sells into the same European hospital channel.
• GE HealthCare: GE HealthCare offers continuous ward monitoring solutions (e.g., CARESCAPE, Mural) serving the same clinical workflow as viQtor in European and global hospitals. Comparable as a broad incumbent in patient monitoring adjacent to SmartQare's general-ward gap-target.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/smartqare

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smartqare